ARCHIVES

Small Phase II Study Finds New Oral Agent May Slow Progression Of Difficult Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

Eight Scientists Receive $800,000 From Milken

January 12, 1990

Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors.

June 17, 2005

NiH Conference: More Discord Than Consensus At Statement’s Presentation

January 31, 1997

LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter.

October 17, 2008

Congress Holds Recision Hearings

February 28, 1975

DCAB Board Okays One Contract Concept, Sends Another Back to Drawing Board

May 22, 1981